Product
BUROSUMAB (INYECTABLE)
Code 100454 · Official unit: AMPOLLA
$ 103.433.916
Reported spend
89Contracts
1Buying agencies
2Suppliers
137Items bought2023–2025
The Uruguayan state bought BUROSUMAB (INYECTABLE) across 89 awards between 2023 and 2025. 1 agencies took part. The agency that bought most is Dirección General de la Salud. The supplier that sold most is LABORATORIO LIBRA SOCIEDAD ANONIMA.
Purchases by year
Who buys it
Agencies that bought this product most often.
Who sells it
Suppliers that sold this product to the state most often.
Supplier concentration
How few suppliers account for this product's purchases: few suppliers signals a captive market.
Price dispersion
Unit-price range per currency and unit (p25 – p50 – p95). The wider the bar, the more what's paid varies.
Price reference
Price distribution per unit and currency over the last 36 months — the same baseline the price flags use.
| Unit | Typical (median) | Usual range | Comparables |
|---|---|---|---|
| USD · comprimido | US$ 11.766 USD | US$ 7.844 – 15.900 | 126 |